HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Heavily Treatment-Experienced Patients and Management of Multi-Drug Resistant HIV-1 Infections - Episode 8

Treatment Options for Heavily Treatment-Experienced Patients with Multi-Drug Resistant HIV

, ,

Joseph Eron, MD, Daniel R. Kuritzkes, MD, and Monica Gandhi, MD, MPH, explore the relative pros and cons of various agents and drug classes that may be used for the treatment of multi-drug resistant HIV.

EP. 1: Prevalence and Challenges Associated With Multi-Drug Resistant HIV Infections
EP. 2: Understanding Risks of Developing Multi-Drug Resistant HIV
EP. 3: The Impact of Drug Resistance on Treatment Efficacy
EP. 4: Approaches to Initial Treatment Selection
EP. 5: Discussing HIV Drug Resistance With Patients
EP. 6: Managing Patients With Suboptimal Treatment Response
EP. 7: Exploring the State of HIV Resistance Testing
Now Viewing
EP. 8: Treatment Options for Heavily Treatment-Experienced Patients with Multi-Drug Resistant HIV
EP. 9: Challenges and Limitations of Current Regimens for Multidrug-Resistant HIV
EP. 10: Mechanisms and Clinical Use of Lenacapavir for Multidrug-Resistant HIV

Related Content:

Heavily Treatment-Experienced Patients and Management of Multi-Drug Resistant HIV-1 InfectionsPeer ExchangeHIV / AIDS
Significant Barriers Keep Patients from Adopting Injectable PrEP
Mechanisms and Clinical Use of Lenacapavir for Multidrug-Resistant HIV
Challenges and Limitations of Current Regimens for Multidrug-Resistant HIV